— Know what they know.
Not Investment Advice

IMMB OTC

Immunotech Laboratories, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +100.0% 1Y: +100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $114993 mcap · 575M float · 0.0007% daily turnover

Balance Sheet Trends

Total Assets
$11M +0.0% ▲
5Y CAGR: +356.8%
Total Liabilities
$6M +0.0% ▲
5Y CAGR: +56.9%
Shareholders Equity
$5M +0.0% ▲
Cash & Investments
$14K +0.0% ▲
5Y CAGR: +22.0%
Total Debt
$2M +0.0% ▲
5Y CAGR: +130.1%
Net Debt
$2M +0.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2004FY2005FY2009FY2013FY2016
— Assets —
Cash$259$47K$5K$633$14K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$259$47K$5K$633$14K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$259$47K$5K$633$14K
Property, Plant & Equip.$0$0$415K$354K$305K
Goodwill & Intangibles$0$0$10M$10M$10M
Long-Term Investments$0$0$0$200K$200K
Other Non-Current Assets$0$3K$19K$0$0
Total Non-Current Assets$0$3K$10M$11M$11M
Total Assets$259$50K$10M$11M$11M
— Liabilities —
Accounts Payable$203K$150K$450K$0$0
Short-Term Debt$38K$0$0$0$773K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$142K$405K$0$3M$2M
Total Current Liabilities$626K$1M$959K$3M$4M
Long-Term Debt$0$0$1M$2M$2M
Other Non-Current Liab.$0$0$2M$0$0
Total Non-Current Liabilities$0$0$3M$2M$2M
Total Liabilities$626K$1M$4M$5M$6M
— Equity —
Common Stock$55K$15K$0$453K$575K
Retained Earnings-$3M-$37M$0-$3M-$4M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$626K-$1M$7M$6M$5M
Total Liabilities & Equity$259$50K$10M$11M$11M
— Key Metrics —
Total Debt$38K$0$1M$2M$2M
Net Debt$37K-$47K$1M$2M$2M
Total Investments$0$0$0$200K$200K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms